Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjun Tian

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Neuropsychiatric Disease and Treatment|September 17, 2025
Exploring the Morphological Study of the Brain in Patients with Bipolar Disorder Based on Structural Magnetic Resonance ImagingJiayue Chen, Hongjun Tian, Xinxin Zhang, et al.
The Journal of Nervous and Mental Disease|July 2, 2019
Does Depressive-Type Schizophrenia Exist? How Do We Prove It?: An Updated Review and OverviewJianjie Huang, Chuanjun Zhuo, Xueqin Song, et al.
Brain Imaging and Behavior|January 16, 2020
Differences in functional connectivity density among subtypes of schizophrenic auditory hallucinationChuanjun Zhuo, Gongying Li, Feng Ji, et al.
The Journal of International Medical Research|January 1, 2020
Treatment of auditory verbal hallucinations with atypical antipsychotics in healthy individuals: an artificially controlled post-treatment reportPeiwei Shan, Chuanjun Zhuo, Xiaoyan Ma, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 13, 2018
Schizophrenia and gut-flora related epigenetic factorsChuanjun Zhuo, Yudong Yao, Yong Xu, et al.
Journal of Affective Disorders|February 22, 2025
Exploring the potential antidepressant mechanisms of ibuprofen and celecoxib based on network pharmacology and molecular dockingQiuyu Zhang, Lei Yang, Chao Li, et al.
Schizophrenia (Heidelberg, Germany)|October 14, 2023
Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot studyChuanjun Zhuo, Shuiqing Hu, Guangdong Chen, et al.
Brain and Behavior|August 11, 2023
Validation of a modified Chinese-language version of the Davos Assessment of Cognitive Biases Scale (MCL-DACOBS) in a sample of Chinese patients with schizophreniaGuangdong Chen, Ranli Li, Hongjun Tian, et al.
Neuroscience Letters|May 18, 2020
Depressive symptoms combined with auditory hallucinations are accompanied with severe gray matter brain impairments in patients with first-episode untreated schizophrenia - A pilot study in ChinaChuanjun Zhuo, Xuexin Xu, Xiaodong Lin, et al.
Frontiers in Psychiatry|October 31, 2022
Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up studyChuanjun Zhuo, Guangdong Chen, Jiayue Chen, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Neuropsychiatric Disease and Treatment|September 17, 2025
Exploring the Morphological Study of the Brain in Patients with Bipolar Disorder Based on Structural Magnetic Resonance ImagingJiayue Chen, Hongjun Tian, Xinxin Zhang, et al.
The Journal of Nervous and Mental Disease|July 2, 2019
Does Depressive-Type Schizophrenia Exist? How Do We Prove It?: An Updated Review and OverviewJianjie Huang, Chuanjun Zhuo, Xueqin Song, et al.
Brain Imaging and Behavior|January 16, 2020
Differences in functional connectivity density among subtypes of schizophrenic auditory hallucinationChuanjun Zhuo, Gongying Li, Feng Ji, et al.
The Journal of International Medical Research|January 1, 2020
Treatment of auditory verbal hallucinations with atypical antipsychotics in healthy individuals: an artificially controlled post-treatment reportPeiwei Shan, Chuanjun Zhuo, Xiaoyan Ma, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 13, 2018
Schizophrenia and gut-flora related epigenetic factorsChuanjun Zhuo, Yudong Yao, Yong Xu, et al.
Journal of Affective Disorders|February 22, 2025
Exploring the potential antidepressant mechanisms of ibuprofen and celecoxib based on network pharmacology and molecular dockingQiuyu Zhang, Lei Yang, Chao Li, et al.
Schizophrenia (Heidelberg, Germany)|October 14, 2023
Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot studyChuanjun Zhuo, Shuiqing Hu, Guangdong Chen, et al.
Brain and Behavior|August 11, 2023
Validation of a modified Chinese-language version of the Davos Assessment of Cognitive Biases Scale (MCL-DACOBS) in a sample of Chinese patients with schizophreniaGuangdong Chen, Ranli Li, Hongjun Tian, et al.
Neuroscience Letters|May 18, 2020
Depressive symptoms combined with auditory hallucinations are accompanied with severe gray matter brain impairments in patients with first-episode untreated schizophrenia - A pilot study in ChinaChuanjun Zhuo, Xuexin Xu, Xiaodong Lin, et al.
Frontiers in Psychiatry|October 31, 2022
Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up studyChuanjun Zhuo, Guangdong Chen, Jiayue Chen, et al.
Pageof 15